300750 Contemporary Amperex Technology (A)

DGAP-News: Woodbridge Buys-Out Joint Venture Partner in China to Enhance Regional Growth Opportunities

DGAP-News: Woodbridge / Key word(s): Miscellaneous
Woodbridge Buys-Out Joint Venture Partner in China to Enhance Regional Growth Opportunities

23.09.2019 / 08:03
The issuer is solely responsible for the content of this announcement.


Troy, Michigan--(Newsfile Corp. - September 23, 2019) - Woodbridge, a global systems solution provider of fully-integrated foam products, announces it has entered into a formal agreement to acquire all the shares in its joint venture, Woodbridge GSK High Polymer Technology Co., Ltd. (WGSK), from its partner GSK Corporation. The transaction will enable Woodbridge to enhance its growth opportunities with its customers located in China.

Upon regulatory approval, GSK's shares will be transferred to Woodbridge. The acquisition includes molded foam manufacturing operations in China: Wuhan (WGSK), Guangzhou (Guangzhou Woodbridge GSK High Polymer Technology Co., Ltd.) and Shanghai (Shanghai Woodbridge GSK Auto Parts Co., Ltd.).

"Woodbridge has been the management partner and technology provider of these three sites for 14 years," said Woodbridge president and CEO Charles Daly. "These facilities will allow our technical expertise, operational excellence and proven track record to continue to be a powerful platform to accelerate growth within the region."

According to Greg Yan, Woodbridge general manager, China, "On behalf of the entire team, I would like to thank GSK for their partnership and wish them continued success. Today marks an exciting chapter for us and reflects the collective efforts of our entire team and we look forward to our future in China."

Following the completion of the sale, Woodbridge will continue to supply molded foam to GSK's seat assembly operations.

About Woodbridge
​Woodbridge is a privately-owned company offering innovative material technologies for applications in automotive, commercial, recreational, packaging, healthcare and building products. In addition to its manufacturing operations, Woodbridge offers a full complement of services including: chemical research and development, product and process engineering, tooling, technical support and accredited laboratory testing. Woodbridge operates more than 60 facilities across 10 countries-employing over 7,500 teammates and serving more than 600 customers worldwide. To learn more, visit .

Media Contacts:
Eric Turmel, Marketing Manager
(248) 280-6322

Greg Yan, General Manager, China
011-86-21-3173-5912, ext. 6522

To view the source version of this press release, please visit

newsinfo.php?i=48005&f=169

Click on, or paste the following link into your web browser,to view the associated documents /release/48005
News Source: Newsfile


23.09.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Woodbridge
United States
EQS News ID: 877817

 
End of News DGAP News Service

877817  23.09.2019 

fncls.ssp?fn=show_t_gif&application_id=877817&application_name=news&site_id=research_pool
EN
23/09/2019

Underlying

300750Contemporary Amperex Technology (A)

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Contemporary Amperex Technology (A)

 PRESS RELEASE

DGAP-News: ADL Bionatur Solutions Wins New Fermentation Client With Co...

DGAP-News: ADL Bionatur Solutions / Key word(s): Agreement ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million 02.12.2019 / 09:06 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS WINS NEW FERMENTATION CLIENT WITH CONTRACT REVENUES OF EUR 20 MILLION The agreement with a leading Swiss biotech company includes technology transfer, upscaling and industrial-scale production of high value-added innovative ingredients for the cosmetics and nutrition industry ADL to apply its expertise in a...

 PRESS RELEASE

Admission of Security to Trading

NEX Exchange (NEXX) Admission of Security to Trading 02-Dec-2019 / 07:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. The following security will be admitted to trading on the NEX Exchange Growth Market with effect from 08:00, 02/12/2019. Name of Issuer: Dozens Savings Plc 5.00% Secured Bonds due 2 December 2020 ISIN: GB00BL1GTZ11  Symbol: DS04 EMS: 1 The Regulation Department NEX Exchange London Fruit & Wool Exchange 1 Duval Square London E1 6PW Tel: 020 7858 1655 Email:   W...

 PRESS RELEASE

Admission of Security to Trading

NEX Exchange (NEXX) Admission of Security to Trading 02-Dec-2019 / 07:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. The following security will be admitted to trading on the NEX Exchange Growth Market with effect from 08:00, 02/12/2019. Name of Issuer: SAPO PLC Ordinary Shares of GBP 0.01 ISIN: GB00B16GQJ90 Symbol: SAPO EMS: 5000 The Regulation Department NEX Exchange London Fruit & Wool Exchange 1 Duval Square London E1 6PW Tel: 020 7858 1655 Email:   Website: ...

 PRESS RELEASE

EQS-News: LIWET HOLDING AG publishes open letter to Dr. Martin Haefner...

EQS Group-News: Dynamics Group AG / Key word(s): Statement/Corporate Action LIWET HOLDING AG publishes open letter to Dr. Martin Haefner in various Swiss Sunday newspapers 01.12.2019 / 05:59 Open letter to Dr. Martin Haefner Dear Mr Haefner We share your concern about the future of Schmolz+Bickenbach (S+B). The company urgently needs money, everyone - including Liwet - agrees. However, there is still time to find a constructive solution for S+B that is in the interest of all, not only one particular shareholder. Liwet is ready to rescue the company and the 10,000 jobs. Liw...

 PRESS RELEASE

EQS-News: LIWET HOLDING AG publiziert offenen Brief an Dr. Martin Haef...

EQS Group-News: Dynamics Group AG / Schlagwort(e): Stellungnahme/Kapitalmaßnahme LIWET HOLDING AG publiziert offenen Brief an Dr. Martin Haefner in verschiedenen Schweizer Sonntagszeitungen 01.12.2019 / 05:59 Offener Brief an Dr. Martin Haefner Sehr geehrter Herr Haefner Wir teilen Ihre Sorge um die Zukunft von Schmolz+Bickenbach (S+B). Die Firma braucht dringend Geld; damit sind alle - auch Liwet - einverstanden. Noch bleibt Zeit, um eine konstruktive Lösung für S+B zu finden, die im Interesse aller Aktionäre ist, nicht nur eines einzigen. Liwet steht bereit, die Fir...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch